CLINICAL TRIALS PROFILE FOR BONJESTA
✉ Email this page to a colleague
All Clinical Trials for BONJESTA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05289557 ↗ | A Multicenter Trial of the Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents | Not yet recruiting | Health Decisions | Phase 3 | 2022-04-01 | The primary objective of this study is to compare the efficacy of Bonjesta for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Bonjesta in pregnant adolescents aged 12 to 17 years with placebo. |
NCT05289557 ↗ | A Multicenter Trial of the Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents | Not yet recruiting | Duchesnay Inc. | Phase 3 | 2022-04-01 | The primary objective of this study is to compare the efficacy of Bonjesta for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Bonjesta in pregnant adolescents aged 12 to 17 years with placebo. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BONJESTA
Condition Name
Clinical Trial Progress for BONJESTA
Clinical Trial Phase
Clinical Trial Sponsors for BONJESTA
Sponsor Name